End Stage Renal Disease Drugs Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global end stage renal disease drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). End stage kidney disease, also known as the late-stage renal disease, refers to a medical condition when chronic kidney disease reaches an advanced or its last stage. In this disease, the kidneys fail to work, as they otherwise function in order to meet the body's needs. The market growth for their drugs is majorly attributed to the growing number of patients suffering from kidney failure, all over the globe. Factors that increase the risk of end stage renal disease include smoking, hypertension, diabetes, and the geriatric population. In fact, the most common factor includes diabetes, whereas hypertension (high blood pressure) is considered to be the second most frequent cause of this disease.
To Request a Sample of our Report on End Stage Renal
Disease Drugs Market: https://www.omrglobal.com/request-sample/end-stage-renal-disease-drugs-market
According to the National Kidney Foundation (NKD),
approximately 10% of the global population suffers from chronic kidney diseases
and millions die each year. As per the same source, the geriatric population
suffers the condition most in emerging economies such as China and India. The
number of patients continues to increase at a rate of 5-7% per year. Chronic
kidney disease is estimated to be more common in women than men (15% vs 12%).
Adding to this, the constantly growing number of patients suffering from
hypertension and diabetes are also likely to fuel the end stage renal disease
drugs market growth. As per the World Health Organization (WHO), in 2019,
around 1.13 billion people globally had hypertension. Adding to this, from
2014-2016, hypertension and diabetes were responsible for nearly 75% of the
global kidney failure cases.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
•
By Type
•
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
Pfizer Inc., Novartis International AG, and Eli Lilly and Co., among others.
(Get 15% Discount on Buying this Report)
A
full Report of End Stage Renal Disease Drugs Market is Available @ https://www.omrglobal.com/industry-reports/end-stage-renal-disease-drugs-market
Global End Stage Renal Disease Drugs Market Report by
Segment
By Type
•
Calcium Succinate
•
Mk-3866
•
Sanguinate
•
Pacritinib
•
Others
By Application
• Hospitals
• Clinics
• Research
Institutes
Global End Stage Renal Disease Drugs Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment